ANNX – annexon, inc. - common stock (US:NASDAQ)
Stock Stats
News
Guillain-Barré Syndrome (GBS) Drug Development Pipeline Research Report 2025 Featuring Annexon and Hansa Biopharma [Yahoo! Finance]
Annexon, Inc. (NASDAQ: ANNX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones [Yahoo! Finance]
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
Form S-8 Annexon, Inc.
Form 4 Annexon, Inc. For: Feb 27 Filed by: ARTIS DEAN RICHARD
Form 4 Annexon, Inc. For: Feb 27 Filed by: Dananberg Jamie
Form 4 Annexon, Inc. For: Feb 27 Filed by: Lew Jennifer
Form 4 Annexon, Inc. For: Feb 27 Filed by: Love Douglas
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.